Abnormal regulation of permeability glycoprotein (P-gp) may be associated with cognitive impairment in AD, and rifampicin can upregulate P-gp expression (Yulug et al., 2014; Kaur and Sodhi, 2015). This evidence concerns the gene PGP and Alzheimer disease.